|
Goldline Pharmaceutical Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
38.40 Cr.
|
P/BV
|
2.90
|
Book Value (Rs.)
|
13.80
|
|
52 Week High/Low (Rs.)
|
60/33
|
FV/ML
|
10/3000
|
P/E(X)
|
9.33
|
|
Bookclosure
|
|
EPS (Rs.)
|
4.29
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 17.31 | 13.89 |
| Total Income From Operations | 17.31 | 13.89 |
| Purchase of Traded Goods | 4.76 | 5.86 |
| Increase/Decrease in Stocks | 1.11 | -0.55 |
| Employees Cost | 3.74 | 3.33 |
| Depreciation | 0.12 | 0.12 |
| Other Expenses | 3.38 | 2.61 |
| Total Expenses | 13.12 | 11.37 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 4.18 | 2.52 |
| P/L Before Interest, Excpt. Items & Tax | 4.18 | 2.52 |
| Interest | 0.65 | 0.67 |
| P/L Before Exceptional Items & Tax | 3.53 | 1.85 |
| P/L Before Tax | 3.53 | 1.85 |
| Tax | 0.77 | 0.50 |
| P/L After Tax from Ordinary Activities | 2.76 | 1.36 |
| Net Profit/Loss For the Period | 2.76 | 1.36 |
| | | |
| Equity Share Capital | 6.90 | 6.90 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 3.43 | 1.96 |
| Diluted EPS (Rs.) | 3.43 | 0.20 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 3.43 | 1.96 |
| Diluted EPS (Rs.) | 3.43 | 0.00 |
| | | |
| PBITOE Margin (%) | 24.16 | 18.11 |
| PBTE Margin (%) | 20.42 | 13.32 |
| PBT Margin (%) | 20.42 | 13.32 |
| PAT Margin (%) | 15.95 | 9.75 |
